An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904to Evaluate the Safety, Tolerability, and Efficacy of EfgartigimodPH20 SC in Patients With Pemphigus

Project: Research project

Project Details

Description

An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus
StatusActive
Effective start/end date9/17/209/30/25

Funding

  • Argenx

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.